Ads
related to: fda approved
Search results
FDA panel votes against MDMA therapy for PTSD, citing muddy data and safety concerns
BioPharma Dive via Yahoo Finance· 14 hours agoA group of independent experts wasn't convinced by clinical trial data from company Lykos...
FDA sets panel review for IceCure's breast cancer treatment By Investing.com
Investing.com· 16 hours agoThe U.S. Food and Drug Administration (FDA) is set to convene a Medical Device Advisory Committee...
FDA panel votes against ecstasy for PTSD
Axios· 10 hours agoWhy it matters: While there's a growing effort to use hallucinogenic substances as behavioral health treatments, regulators are grappling with how to...
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 2 days agoIn 2023, Moderna agreed to establish an mRNA manufacturing facility in Kenya. The new advanced facility will have the capacity to produce up to 500...
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
ABC News· 16 hours agoThe Food and Drug Administration convened a panel of outside experts Tuesday to review the latest...
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
WFMJ Youngstown· 14 hours agoBecause of those risks, the FDA has proposed strict limits on how and where MDMA could be used if ...
FDA approves Moderna's mRNA RSV vaccine for older adults
News Channel Nebraska· 1 day agoBy Jen Christensen, CNN
‘Frances Oldham Kelsey, the FDA, and the Battle Against Thalidomide’ Review: The Noble Bureaucrat
The Wall Street Journal· 15 hours agoAt the FDA, her job involved rejecting or approving applications for new drugs. In September 1960, a...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 4 days agoModerna's vaccine was approved for the prevention of RSV-associated lower respiratory tract disease...
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
Detroit News· 13 hours agoThe Food and Drug Administration convened a panel of outside experts Tuesday to review the latest...
